For the roughly 180,000 Australians living with inflammatory bowel disease, remission has long carried a quiet uncertainty — the body feels well, yet the disease returns without warning. Researchers at the Walter and Eliza Hall Institute have now found a molecular reason for that uncertainty: intestinal cells in IBD patients remain primed to die even when symptoms have vanished, a smoldering defect that appears to drive the disease rather than merely follow from it. Studying nearly 900 biopsies and patient-grown mini-intestines, the team has begun to map what true remission might actually requ
Scientists discover hidden cellular defect that triggers IBD relapses even during remission
IBD affects approximately 180,000 Australians and causes serious symptoms including rectal bleeding, abdominal pain, diarrhea, fatigue, weight loss, and requires hospitalization during severe flare-ups.